share_log

monday.com | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

SEC ·  Aug 29 17:26
Summary by Moomoo AI
On August 29, 2024, monday.com Ltd., a foreign private issuer, filed a prospectus supplement with the U.S. Securities and Exchange Commission (SEC) under Rule 424(b) of the Securities Act of 1933. This filing pertains to the potential resale of up to 68,000 ordinary shares by the monday.com Foundation Ltd. The company has also included an opinion from its Israeli counsel, Meitar Law Offices, addressing certain Israeli law issues related to the ordinary shares that may be sold. This report, along with the exhibits, will be incorporated into the company's existing Registration Statements on Form F-3, enhancing the legal framework for the potential transaction. The report emphasizes that it should not be considered an offer to sell or a solicitation of an offer to buy the shares in any jurisdiction where such an offer or sale would be illegal without proper registration or qualification under applicable securities laws.
On August 29, 2024, monday.com Ltd., a foreign private issuer, filed a prospectus supplement with the U.S. Securities and Exchange Commission (SEC) under Rule 424(b) of the Securities Act of 1933. This filing pertains to the potential resale of up to 68,000 ordinary shares by the monday.com Foundation Ltd. The company has also included an opinion from its Israeli counsel, Meitar Law Offices, addressing certain Israeli law issues related to the ordinary shares that may be sold. This report, along with the exhibits, will be incorporated into the company's existing Registration Statements on Form F-3, enhancing the legal framework for the potential transaction. The report emphasizes that it should not be considered an offer to sell or a solicitation of an offer to buy the shares in any jurisdiction where such an offer or sale would be illegal without proper registration or qualification under applicable securities laws.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more